Rapport Therapeutics, Inc. Common StockRAPPNASDAQ
Loading
EPS Growth Under PressureDecelerating
Percentile Rank64
Studio
Year-over-Year Change

Year-over-year earnings per share growth rate

Latest
-1.41%
↑ 98% vs avg
Percentile
P64
Within normal range
Streak
1 qtr
Consecutive declineDecelerating
Average
-57.95%
Historical baseline
PeriodValue
Q4 2025-1.41%
Q3 20255.33%
Q2 2025-525.00%
Q1 2025-20.00%
Q4 2024-9.29%
Q3 2024-1.55%
Q2 202424.92%
Q1 2024-60.43%
Q4 2023-64.04%
Q3 2023-42.95%
Q2 2023-0.95%
Q1 20230.00%